Priority Review for Abatacept BLA Granted by the FDA for GVHD Prophylaxis – Cancer Network
Priority Review for Abatacept BLA Granted by the FDA for GVHD Prophylaxis Cancer NetworkFDA grants priority review to Orencia for acute GVHD prevention HealioAbatacept Gets Priority Review for Moderate to Severe Acute Graft Versus…
